Fundraising Fox
AxioMed
Malden, US · Founded 2014 · 3 known investors
Find your way into AxioMed
Sign up to see every warm intro you have to AxioMed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AxioMed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AxioMed develops motion-preserving spinal disc replacement technologies designed to treat early-stage spine degeneration, shifting care away from fusion surgery toward minimally invasive procedures performed in ambulatory surgery centers. The company targets the spine surgery market in the United States with patented biomimetic disc technologies that restore natural spinal mechanics.
Founders & leadership
Board
AH
Investors · 3
Funding
SEC filings, press & company announcements$1.4M disclosed across 3 of 6 rounds · 2016–2026
▶$320KraisedMar 2023 · 6 investors · Other Health CareRule 506(c)
▶$320KraisedMar 2023 · 6 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Aditya HumadExecutive Officer
- Offering amount
- $30M
- Amount sold
- $320K
- Minimum investment
- $50K
- Placement agents
- NA
- First sale
- Nov 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06c
▶$100KraisedNov 2017 · 1 investors · Other Health CareRule 506(c)
▶$100KraisedNov 2017 · 1 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Aditya HumadExecutive Officer
- Offering amount
- $10M
- Amount sold
- $100K
- Minimum investment
- $50K
- Proceeds to insiders
- $25K
- First sale
- Nov 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06c
▶$1MraisedJan 2017 · 3 investors · Other Health CareRule 506(c)
▶$1MraisedJan 2017 · 3 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Aditya HumadExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1M
- Minimum investment
- $25K
- Proceeds to insiders
- $35K
- First sale
- Nov 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does AxioMed do?
- AxioMed develops motion-preserving spinal disc replacement technologies designed to treat early-stage spine degeneration, shifting care away from fusion surgery toward minimally invasive procedures performed in ambulatory surgery centers. The company targets the spine surgery market in the United States with patented biomimetic disc technologies that restore natural spinal mechanics.
- Who are AxioMed's investors?
- AxioMed's investors include KIC Ventures, Western Technology Investment, Extantia Capital.
- How much funding has AxioMed raised?
- AxioMed has disclosed $1.4M raised across 3 of its 6 known rounds.
- Where is AxioMed headquartered?
- AxioMed is headquartered in Malden, US.